Atwood & Palmer’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $109K | Buy |
849
+77
| +10% | +$9.01K | 0.01% | 197 |
|
|
2026
Q1 | $92.9K | Buy |
772
+42
| +6% | +$4.85K | 0.01% | 202 |
|
|
2025
Q4 | $76.8K | Hold |
730
| – | – | ﹤0.01% | 206 |
|
|
2025
Q3 | $61.3K | Hold |
730
| – | – | ﹤0.01% | 228 |
|
|
2025
Q2 | $57.8K | Hold |
730
| – | – | ﹤0.01% | 229 |
|
|
2025
Q1 | $65.5K | Hold |
730
| – | – | ﹤0.01% | 207 |
|
|
2024
Q4 | $72.6K | Hold |
730
| – | – | 0.01% | 201 |
|
|
2024
Q3 | $82.9K | Hold |
730
| – | – | 0.01% | 199 |
|
|
2024
Q2 | $90.4K | Hold |
730
| – | – | 0.01% | 191 |
|
|
2024
Q1 | $96.3K | Buy |
730
+150
| +26% | +$18.5K | 0.01% | 187 |
|
|
2023
Q4 | $63.2K | Hold |
580
| – | – | 0.01% | 210 |
|
|
2023
Q3 | $59.7K | Hold |
580
| – | – | 0.01% | 207 |
|
|
2023
Q2 | $66.9K | Buy |
580
+25
| +5% | +$2.84K | 0.01% | 209 |
|
|
2023
Q1 | $59K | Hold |
555
| – | – | 0.01% | 200 |
|
|
2022
Q4 | $61.6K | Hold |
555
| – | – | 0.01% | 201 |
|
|
2022
Q3 | $48K | Hold |
555
| – | – | ﹤0.01% | 201 |
|
|
2022
Q2 | $51K | Sell |
555
-282
| -34% | -$25K | 0.01% | 208 |
|
|
2022
Q1 | $69K | Buy |
837
+134
| +19% | +$10.6K | 0.01% | 201 |
|
|
2021
Q4 | $54K | Buy |
703
+71
| +11% | +$5.66K | ﹤0.01% | 224 |
|
|
2021
Q3 | $47K | Buy |
632
+100
| +19% | +$7.61K | ﹤0.01% | 227 |
|
|
2021
Q2 | $41K | Sell |
532
-356
| -40% | -$26.5K | ﹤0.01% | 236 |
|
|
2021
Q1 | $65K | Buy |
888
+364
| +69% | +$26.9K | 0.01% | 203 |
|
|
2020
Q4 | $41K | Hold |
524
| – | – | ﹤0.01% | 227 |
|
|
2020
Q3 | $41K | Hold |
524
| – | – | 0.01% | 205 |
|
|
2020
Q2 | $39K | Hold |
524
| – | – | 0.01% | 202 |
|
|
2020
Q1 | $38K | Hold |
524
| – | – | 0.01% | 196 |
|
|
2019
Q4 | $45K | Hold |
524
| – | – | 0.01% | 189 |
|
|
2019
Q3 | $42K | Sell |
524
-152
| -22% | -$12.2K | 0.01% | 196 |
|
|
2019
Q2 | $54K | Sell |
676
-56
| -8% | -$4.29K | 0.01% | 176 |
|
|
2019
Q1 | $58K | Hold |
732
| – | – | 0.01% | 170 |
|
|
2018
Q4 | $53K | Sell |
732
-526
| -42% | -$37.1K | 0.01% | 170 |
|
|
2018
Q3 | $85K | Sell |
1,258
-45
| -3% | -$2.87K | 0.01% | 162 |
|
|
2018
Q2 | $75K | Sell |
1,303
-3,203
| -71% | -$181K | 0.01% | 165 |
|
|
2018
Q1 | $234K | Sell |
4,506
-2,384
| -35% | -$129K | 0.03% | 116 |
|
|
2017
Q4 | $370K | Hold |
6,890
| – | – | 0.05% | 98 |
|
|
2017
Q3 | $421K | Sell |
6,890
-52
| -0.7% | -$3.15K | 0.06% | 90 |
|
|
2017
Q2 | $425K | Buy |
6,942
+786
| +13% | +$47.8K | 0.07% | 89 |
|
|
2017
Q1 | $373K | Buy |
6,156
+2,025
| +49% | +$123K | 0.06% | 91 |
|
|
2016
Q4 | $232K | Hold |
4,131
| – | – | 0.04% | 106 |
|
|
2016
Q3 | $246K | Buy |
4,131
+71
| +2% | +$4.15K | 0.04% | 101 |
|
|
2016
Q2 | $223K | Hold |
4,060
| – | – | 0.04% | 105 |
|
|
2016
Q1 | $205K | Sell |
4,060
-4,535
| -53% | -$222K | 0.04% | 110 |
|
|
2015
Q4 | $433K | Hold |
8,595
| – | – | 0.08% | 94 |
|
|
2015
Q3 | $405K | Hold |
8,595
| – | – | 0.08% | 95 |
|
|
2015
Q2 | $467K | Hold |
8,595
| – | – | 0.08% | 97 |
|
|
2015
Q1 | $471K | Buy |
8,595
+288
| +3% | +$16.3K | 0.08% | 98 |
|
|
2014
Q4 | $451K | Sell |
8,307
-151
| -2% | -$8.41K | 0.08% | 94 |
|
|
2014
Q3 | $478K | Buy |
8,458
+3,859
| +84% | +$217K | 0.09% | 94 |
|
|
2014
Q2 | $254K | Sell |
4,599
-4,085
| -47% | -$223K | 0.07% | 105 |
|
|
2014
Q1 | $470K | Hold |
8,684
| – | – | 0.11% | 78 |
|
|
2013
Q4 | $415K | Hold |
8,684
| – | – | 0.1% | 81 |
|
|
2013
Q3 | $394K | Buy |
8,684
+524
| +6% | +$23.9K | 0.11% | 79 |
|
|
2013
Q2 | $362K | Buy |
+8,160
| New | +$364K | 0.1% | 79 |
|
Other funds holding MRK
LMFP
ATO
QP
Atwood & Palmer's MRK Position: Q2 2026 in Review
Atwood & Palmer increased its Merck (MRK) stake by 10% in Q2 2026, buying an estimated $9.01K and bringing the position to 849 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #197.
Atwood & Palmer first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $478K in Q3 2014. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Atwood & Palmer held 849 shares of Merck worth $109K as of Q2 2026.
- Atwood & Palmer bought 77 Merck shares in Q2 2026, an estimated $9.01K.
- Merck made up 0.01% of Atwood & Palmer's portfolio in Q2 2026, its #197 holding.
- Atwood & Palmer first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Atwood & Palmer's Merck position peaked at $478K in Q3 2014.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.